Grifols and Brookfield said they aren't in takeover talks, after a media report indicated the investment company had resumed discussions with the Grifols family--which controls the Spanish pharmaceutical company--about a possible deal.
"Brookfield is not, and has not been, in discussions with the company's board of directors with respect to a potential transaction," Brookfield said.
The investor said it maintains a general dialogue with Grifols's reference shareholders, but said there is no update since it decided against making a bid for the company in November.
Grifols's board said separately that it "has no knowledge" of talks regarding another attempt by Brookfield to acquire the company.
The statements came after Spanish news website El Confidencial reported, citing unnamed sources, that Brookfield had resumed talks with the Grifols family over a possible deal.
Shares in Grifols traded 6% higher at 8.63 euros in European afternoon trading, paring back gains of as much as 15% earlier in the session, after both Grifols and Brookfield issued their statements.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.